Prevention of Retinal Non-perfusion in Central Retinal Vein Occlusion by Hydroxycarbamide Treatment.
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The central retinal vein occlusion (CRVO) is a major cause of ocular morbidity, depending in
particular on the occurrence and extent of retinal ischemia by capillary occlusion. There is
no effective systemic treatment of this condition. An increase in the adhesion of
erythrocytes to vascular endothelium was observed for patients with CRVO, correlated with
overexpression of membrane phosphatidylserine
Phase:
Phase 2
Details
Lead Sponsor:
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts